The present invention provides novel heterocyclic amides and related derivatives having the general Formula I
1
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, A, B and Z are as defined in the specification, or a nontoxic pharmaceutically acceptable salt, solvate or hydrate thereof which are openers or activators of KCNQ potassium channels. The present invention also provides pharmaceutical compositions comprising said heterocyclic amides and to the method of treatment of disorders sensitive to KCNQ potassium channel opening activity such as migraine or a migraine attack, bipolar disorders, epilepsy, acute and chronic pain and anxiety.
本发明提供了具有一般式I1的新型杂环
酰胺和相关衍
生物,其中R1、R2、R3、R4、R5、R6、A、B和Z如规范中所定义,或其无毒药学上可接受的盐、溶剂或
水合物,它们是KCNQ
钾通道的开放剂或激活剂。本发明还提供了包括上述杂环
酰胺的药物组合物以及对于对KCNQ
钾通道开放活性敏感的疾病的治疗方法,如偏头痛或偏头痛发作、双相障碍、癫痫、急性和慢性疼痛和焦虑。